Wade W. Andrews is a business associate focusing on general corporate law. 

Download full bio 


  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Reneo Pharmaceuticals – $94 Million IPO 

  • Equillium – $65.4 Million IPO 

  • HTG Completes its Initial Public Offering 

  • View all


  • University of California Hastings College of Law
    JD, magna cum laude, 2009

  • Brigham Young University
    BS, 2005